Replay available

OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call

OrthoPediatrics Corp. (NASDAQ: KIDS) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.

Tue, August 5, 2025 at 4:30 PMendedReplay
OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Hannah Jeffrey

Gilmartin Group

Dave Bailey

President and Chief Executive Officer

Fred Height

Chief Operating and Financial Officer

Ryan Zimmerman

Analyst, BTIG

Matthew O'Brien

Analyst, Piper Sandler

Mike Madsen

Analyst, Needham & Company

Ben Hainer

Analyst, Lake Street Capital Markets

Richard Newiter

Analyst, Truist Securities

Replay transcript excerpt

Good afternoon, and welcome to Orthopediatrics Corporation's second quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Hannah Jeffrey from the Gilmartin Group for a few introductory comments. Please begin. Thank you for joining today's call. With me from the company are Dave Bailey, President and Chief Executive Officer, and Fred Height, Chief Operating and Financial Officer. Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meeting of federal securities laws, including the Safe Harbor Provisions for Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties, and the company's actual results may differ materially. For discussion of risk factors, I encourage you to review the company's most recent annual report on Form 10-K, which was filed with the SEC on March 5, 2025, and its subsequent quarterly reports on Form 10-Q. During the call today, management will also discuss certain non-GAAP financial measures, which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period over period. For each non-GAAP financial measure referenced on this call, the company has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in its second quarter earnings release. Please note that the non-GAAP financial measures have limitations as analytical tools and sho...

More from Orthopediatrics Corp.